secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEMETIS, INC (AMTX)
CIK:        0000738214
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001437749-25-025253
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aemetis Q2 2025 revenue $52.2M, net loss $23.4M; India subsidiary IPO targeted early 2026
--------------------------------------------------------------------------------

- Revenue $52.2M, up $9.3M from Q1 2025; gross loss $3.4M vs $1.8M loss a year ago.
- Net loss $23.4M, improved from $29.2M loss in Q2 2024; operating loss $10.7M.
- Aemetis Biogas generated $3.1M from 11 digesters; CARB approved 7 new LCFS pathways.
- Signed $27M agreement with NPL for H₂S and compression units at 15 dairy digesters.
- Appointed new CFO with IPO experience; India subsidiary targeting public listing early 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/738214/000143774925025253/0001437749-25-025253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/738214/000143774925025253/amtx20250806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-025253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer